Todd Sone

Todd Sone has worked in a variety of roles in the healthcare industry since 2009. In that year, they began their career as a Partner at Signet Healthcare Partners. In 2012, they became an Investor at Claris Lifesciences Limited, a specialty pharma focused on injectable and infusion medications. In 2017, they joined aMoon Fund as a General Partner and Partner. In 2018, they became an Investor and Board Director at SMART Medical Systems LTD., Ayala Pharmaceuticals, and Ultima Genomics. In 2019, they added Investor and Board Director roles at Biolojic Design, Ltd., and Theranica Bio-Electronics Ltd. In 2020, they joined MOBILion Systems, Inc. as an Investor and Board Director. In 2021, they began their role as an Investor and Board Director at Scipher Medicine.

Todd Sone attended The Wharton School from 1998 to 2000, earning an MBA in Finance & Healthcare Management. Todd then attended the University of Toronto - University College from 1990 to 1994, where they earned a B. Com. In addition, they attended The Hebrew University of Jerusalem from 1991 to 1992, studying Mideast Studies and History.